Malignant Brain Tumor Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Malignant Brain Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

NeuroPathways Intervention for Brain Tumor Patients

GliomaMalignant Brain TumorCoping Skills
Massachusetts General Hospital50 enrolled1 locationNCT05976490
Recruiting
Phase 1

Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients

Malignant GliomaMalignant Brain TumorEmbryonal Tumor
Assistance Publique - Hôpitaux de Paris24 enrolled3 locationsNCT05293197
Recruiting
Phase 1Phase 2

A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors

Malignant Brain Tumors
China Medical University Hospital10 enrolled2 locationsNCT07003139
Recruiting
Phase 1

Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation

Malignant Brain Tumors
Haisco Pharmaceutical Group Co., Ltd.159 enrolled6 locationsNCT07158710
Recruiting
Not Applicable

FearLess in NeuroOncology

CaregiverGlioblastoma (GBM)Oligodendroglioma+2 more
Virginia Commonwealth University112 enrolled1 locationNCT06989086
Recruiting

A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma

Primary Malignant Brain Tumors
National Health Research Institutes, Taiwan250 enrolled8 locationsNCT05622409
Recruiting

Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease

EpilepsyAlzheimer DiseaseParkinson Disease+1 more
Xuanwu Hospital, Beijing2,300 enrolled1 locationNCT06092125
Recruiting
Not Applicable

ASCENT Intervention for Brain Tumor Patients

Distress, EmotionalGliomaMalignant Brain Tumor+1 more
Massachusetts General Hospital100 enrolled1 locationNCT06099743